Hair Relaxer Uterine Cancer Risks Linked to Endocrine Disruptors and Phthalate Exposure
Women pursuing hair relaxer uterine cancer lawsuits point to DEHP, a phthalate some studies have linked to abnormal uterine and endometrial cell development.
Women pursuing hair relaxer uterine cancer lawsuits point to DEHP, a phthalate some studies have linked to abnormal uterine and endometrial cell development.
Lawsuit alleges L'Oreal and other manufacturers knew about the risk of uterine cancer from hair straightener chemicals, but failed to warn consumers.
Lawsuit alleges that women face a future risk of uterine cancer and other injuries from Dark & Lovely, and other hair straighteners that will require life-long medical monitoring
Hair relaxer lawsuits have been filed in four different federal district courts, and it is expected that hundreds of additional claims will be filed over uterine cancer, breast cancer, fibroids and other injuries
Plaintiffs seek refunds and medical monitoring for women who bought and were exposed to Dark & Lovely hair relaxer chemicals
Plaintiff began using the products when she was only 10 years old, claiming chemicals in the hair relaxers caused uterine cancer to develop when she was 39 years old
Exposure to PFAS chemicals has been tied to 13 major health problems, costing the U.S. healthcare system between $5.5 billion and $63 billion over the current population' lifetime.
The increasing uterine cancer rates appear to disproportionately affect women of color, who may not be getting the same quality of healthcare as other women in the U.S.